Phase II Study of Low-Dose Docetaxel/Estramustine in Elderly Patients or Patients Aged 18-74 Years with Hormone-Refractory Prostate Cancer
Sreeni Chittoor, William Berry, David Loesch, Keith Logie, John Fleagle, Stephanie Mull, Kristi A. Boehm, Feng Zhan, Lina AsmarVolume:
5
Année:
2006
Langue:
english
DOI:
10.3816/cgc.2006.n.039
Fichier:
PDF, 172 KB
english, 2006